These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 9804698

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 2. Overcoming the species difference between guinea pig and man.
    Abe Y, Kayakiri H, Satoh S, Inoue T, Sawada Y, Inamura N, Asano M, Hatori C, Sawai H, Oku T, Tanaka H.
    J Med Chem; 1998 Oct 08; 41(21):4053-61. PubMed ID: 9767642
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. MEN16132, a novel potent and selective nonpeptide antagonist for the human bradykinin B2 receptor. In vitro pharmacology and molecular characterization.
    Cucchi P, Meini S, Bressan A, Catalani C, Bellucci F, Santicioli P, Lecci A, Faiella A, Rotondaro L, Giuliani S, Giolitti A, Quartara L, Maggi CA.
    Eur J Pharmacol; 2005 Dec 28; 528(1-3):7-16. PubMed ID: 16324696
    [Abstract] [Full Text] [Related]

  • 9. Effects of the non-peptide B2 antagonist FR173657 on kinin-induced smooth muscle contraction and relaxation, vasoconstriction and prostaglandin release.
    Griesbacher T, Sametz W, Legat FJ, Diethart S, Hammer S, Juan H.
    Br J Pharmacol; 1997 Jun 28; 121(3):469-76. PubMed ID: 9179388
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological characterization of a nonpeptide bradykinin B2 receptor antagonist, FR165649, and agonist, FR190997.
    Asano M, Hatori C, Sawai H, Johki S, Inamura N, Kayakiri H, Satoh S, Abe Y, Inoue T, Sawada Y, Mizutani T, Oku T, Nakahara K.
    Br J Pharmacol; 1998 Jun 28; 124(3):441-6. PubMed ID: 9647466
    [Abstract] [Full Text] [Related]

  • 11. A new series of highly potent non-peptide bradykinin B2 receptor antagonists incorporating the 4-heteroarylquinoline framework. Improvement of aqueous solubility and new insights into species difference.
    Sawada Y, Kayakiri H, Abe Y, Imai K, Mizutani T, Inamura N, Asano M, Aramori I, Hatori C, Katayama A, Oku T, Tanaka H.
    J Med Chem; 2004 Mar 25; 47(7):1617-30. PubMed ID: 15027853
    [Abstract] [Full Text] [Related]

  • 12. A new class of nonpeptide bradykinin B(2) receptor ligand, incorporating a 4-aminoquinoline framework. Identification of a key pharmacophore to determine species difference and agonist/antagonist profile.
    Sawada Y, Kayakiri H, Abe Y, Mizutani T, Inamura N, Asano M, Aramori I, Hatori C, Oku T, Tanaka H.
    J Med Chem; 2004 May 06; 47(10):2667-77. PubMed ID: 15115408
    [Abstract] [Full Text] [Related]

  • 13. [Discovery of highly potent and orally active non-peptide bradykinin B2 receptor antagonists].
    Kayakiri H.
    Tanpakushitsu Kakusan Koso; 2000 Apr 06; 45(6 Suppl):996-1000. PubMed ID: 10771664
    [No Abstract] [Full Text] [Related]

  • 14. Design and synthesis of novel sulfonamide-containing bradykinin hB2 receptor antagonists. 1. Synthesis and SAR of alpha,alpha-dimethylglycine sulfonamides.
    Fattori D, Rossi C, Fincham CI, Berettoni M, Calvani F, Catrambone F, Felicetti P, Gensini M, Terracciano R, Altamura M, Bressan A, Giuliani S, Maggi CA, Meini S, Valenti C, Quartara L.
    J Med Chem; 2006 Jun 15; 49(12):3602-13. PubMed ID: 16759102
    [Abstract] [Full Text] [Related]

  • 15. Pharmacological characterization of the bradykinin B2 receptor: inter-species variability and dissociation between binding and functional responses.
    Paquet JL, Luccarini JM, Fouchet C, Defrêne E, Loillier B, Robert C, Bélichard P, Cremers B, Pruneau D.
    Br J Pharmacol; 1999 Mar 15; 126(5):1083-90. PubMed ID: 10204994
    [Abstract] [Full Text] [Related]

  • 16. Effects of FR173657, a non-peptide B2 antagonist, on kinin-induced hypotension, visceral and peripheral oedema formation and bronchoconstriction.
    Griesbacher T, Legat FJ.
    Br J Pharmacol; 1997 Mar 15; 120(5):933-9. PubMed ID: 9138701
    [Abstract] [Full Text] [Related]

  • 17. Effects of an orally active non-peptide bradykinin B2 receptor antagonist, FR173657, on plasma exudation in rat carrageenin-induced pleurisy.
    Majima M, Kawashima N, Hiroshi I, Katori M.
    Br J Pharmacol; 1997 Jun 15; 121(4):723-30. PubMed ID: 9208140
    [Abstract] [Full Text] [Related]

  • 18. Differences between peptide and nonpeptide B(2) bradykinin receptor antagonists in blocking bronchoconstriction and hypotension induced by bradykinin in anesthetized Guinea pigs.
    Tramontana M, Lecci A, Meini S, Montserrat X, Pascual J, Giuliani S, Quartara L, Maggi CA.
    J Pharmacol Exp Ther; 2001 Mar 15; 296(3):1051-7. PubMed ID: 11181940
    [Abstract] [Full Text] [Related]

  • 19. Design and synthesis of novel sulfonamide-containing bradykinin hB2 receptor antagonists. 2. Synthesis and structure-activity relationships of alpha,alpha-cycloalkylglycine sulfonamides.
    Fattori D, Rossi C, Fincham CI, Caciagli V, Catrambone F, D'Andrea P, Felicetti P, Gensini M, Marastoni E, Nannicini R, Paris M, Terracciano R, Bressan A, Giuliani S, Maggi CA, Meini S, Valenti C, Quartara L.
    J Med Chem; 2007 Feb 08; 50(3):550-65. PubMed ID: 17266207
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological and functional characterization of the guinea-pig B2 bradykinin receptor stably expressed in CHO-K1 cell line.
    Robert C, Pruneau D, Paquet JL.
    Br J Pharmacol; 2002 Jan 08; 135(2):462-8. PubMed ID: 11815382
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.